Parabilis Medicines, Inc. ($PBLS)
Filing Information
| Accession Number | 0001213900-26-072928 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 29, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
1,554,140
Total Value
$14,996,623.60
P&L
+44.1% (+$4,413,800.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock, par value $0.0001 per share | โ | Jun 11, 2026 | Purchase | 375,000 | $20.00 | $7,500,000.00 | 1,027,000 | Indirect | See footnote | View Details | |
10% Owner | Common Stock, par value $0.0001 per share | โ | Jun 11, 2026 | Purchase | 125,000 | $20.00 | $2,500,000.00 | 652,000 | Indirect | See footnote | View Details | |
10% Owner | Common Stock, par value $0.0001 per share | โ | Jun 11, 2026 | Conversion | 527,070 | $9.48 | $4,996,623.60 | 527,070 | Indirect | See footnote | View Details | |
10% Owner | Series F Preferred Stock | Derivative | Jun 11, 2026 | Conversion | 527,070 | $0.00 | $0.00 | 0 | Indirect | See footnote | View Details |